Sera of patients with systemic lupus erythematosus react with plasmodial antigens and can inhibit the in vitro growth of Plasmodium falciparum

Zanini, Graziela Maria; Carvalho, Leonardo Jose de Moura; Brahimi, Karima; Passos, Luiz Fernando; Guimarães, Swami Jose de Souza; Machado, Eduardo da Silva; Bianco Junior, Cesare; Riccio, Evelyn Kety Pratt; Sousa, Maria Auxiliadora de; Alecrim, Maria das Gracas Costa; Leite, Nocy; Druilhe, Pierre; Daniel-Ribeiro, Cláudio Tadeu.
Artigo em Inglês | Arca: Repositório institucional da Fiocruz | ID: arc-28299

Documentos relacionados

  1. A close-up on the expanding landscape of CD21-/low B cells in humans.
  2. Ro52/TRIM21 - From host defense to autoimmunity.
  3. Age-associated B cells in autoimmune diseases.
  4. Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target.
  5. Systemic lupus erythematosus as a genetic disease.
  6. Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation.
  7. Nanocage-Based Capture-Detection System for the Clinical Diagnosis of Autoimmune Disease.
  8. Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus.
  9. Coexisting systemic lupus erythematosus and suspected hyperimmunoglobulin E syndrome: A case report.
  10. Remnant Epitopes Generating Autoimmunity: From Model to Useful Paradigm.